B

BAALC gene expression, in AML patients, 20 B-and T-cell image in acute lymphoblastic leukemia, 107-108 B-cell lymphomas, 513 approaches to treatment of, 550 Burkitt lymphomas, 520 diagnosis and initial evaluation, 543-544 diffuse large B-cell lymphomas, 507, 509, 519-520 follicular lymphoma, 509, 515-516 initial presentation, 543 initial therapy of localized DLBLL, 546-550 lymphomatoid granulomatosis, 520-521 lymphoplasmacytic lymphoma, 518-519 mantle cell lymphoma, 514-515

mucosa-associated lymphoid tissue lymphomas, 516-517 nodal marginal zone lymphomas, 518 pathologic and prognostic features, 544-545 primary effusion lymphoma, 521 of primary mediastinal, 530-551 relapsed and refractory DLBCL, treatment of, 551 small lymphocytic lymphoma, 513-514 splenic marginal zone lymphoma, 517-518 Bcl-2 compound, 97 BCNU, 3

BCR/ABL-negative CML, 494 BCR/ABL-positive disease, 495 BCR/ABL translocation, 488, 494 BEACOPP regimens, 775 bendamustine, 536 benzolystaurosporine, 97 bestrabucil, 662 bevacizumab, 441 bexarotene, 1110 bilineage leukemia, 35 blastic NK-cell lymphoma, 526 blood transfusion products granulocyte transfusion, 1134 platelet transfusion, 1128-1131 red blood cell transfusion, 1127-1128 specialized blood components, 1131-1134 transfusion in palliative care, 1134-1135 Bloom syndrome, 1, 9 bone marrow aplastic anemia and stem cell failure, 401, 403 biology, 51 biopsy, 87, 466

multiple myeloma and related disorders, 860-861 myelodysplastic syndromes and, 377, 426 myeloma cells and, 865 bone marrow plasma cell labeling index (PCLI), 917 bone marrow transplantation. See also allogeneic stem cell transplantation; autologous stem cell transplantation; hematopoietic stem cell transplantation (HSCT); stem cell transplantation aplastic anemia and, 405 chronic leukemia and, 361 cytokine mobilized PBSC versus, 420 peripheral blood versus bone marrow as source of stem cell, 418 bortezomib, 536, 728, 879 Burkitt-like lymphoma, 509, 520 autologous hematopoietic cell transplantation for, 680-681 clinical features, 570 frequency of occurence, 569-570 pathology and pathogenesis, 570-571 stem cell transplantation, 573 treatment of, 571-572 busulfan, 3, 95, 488, 495, 1089

0 0

Post a comment